Official Journal of the European Society of Gynecology
eISSN 2710-2580
Endocrinology of ovarian aging: Implications for premature ovarian insufficiency
Logo EGO
European Gynecology & Obstetrics
European Society of Gynecology
PDF

Keywords

aging, follicle, oocyte, Ovary, oxidative stress, Premature ovarian insufficiency, somatic follicular cells

Categories

How to Cite

Monllor-Tormos, A., Belda-Montesinos, R., Carrasco-Catena, A., Chedraui, P., & Cano, A. (2024). Endocrinology of ovarian aging: Implications for premature ovarian insufficiency. European Gynecology & Obstetrics, 6(2). https://doi.org/10.53260/EGO.246025

Abstract

Background and aim: To update the mechanisms involved in the process of ovarian aging with a focus on premature ovarian insufficiency (POI). Both the endocrinological and the fertility functions will be reviewed.
Methods: Update of the most relevant publications up to 2023.
Results: The ovary is an organ that has a dual role, as an endocrinological gland for the secretion of steroid hormones, and as a reproductive gonad as a source of oocytes. A main feature of the ovary is that the structures enclosing both the oocytes and the somatic cells, the follicles, which are capable of producing most of the ovarian hormones, replicate only until mid-term of the fetal life. The steroidogenic stromal cells that produce androgens, slowly decrease their activity until late in women’s life. The follicular endowment experiences a progressive wastage up to mid-life, around 50 years of age. The oocytes contained in the follicles of cycles occurring in the later functional reproductive years, suffer a functional impairment that conditions a lower fertility potential. The endocrinological output of follicles extends up to more advanced stages, at the end of the menopausal transition. Dysfunctions in the hormonal output of follicles determine changes in the cycle, including both irregular bleeding and amenorrhea. Women with POI may reproduce similar changes, although the details depend on the etiology and the pathophysiological substrate. The potential underlying mechanisms of ovarian aging are unclear, although oxidative stress seems to have a determining role. Recent data have aided to clarify the molecular details for this effect.
Conclusions: The aging of the ovary translates to mechanisms that condition functional impairment of the oocyte and somatic endocrinological cells, although the progression is dissimilar. 

https://doi.org/10.53260/EGO.246025
PDF

References

Johnson J, Bagley J, Skaznik-Wikiel M, Lee HJ, et al. Oocyte generation in adult mammalian ovaries by putative germ cells in bone marrow and peripheral blood. Cell. 2005;122(2):303-315.

Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature. 2004;428(6979):145-150.

Yoshino T, Suzuki T, Nagamatsu G, et al. Generation of ovarian follicles from mouse pluripotent stem cells. Science. 2021;373(6552):eabe0237.

European Society for Human Reproduction and Embryology (ESHRE) Guideline Group on POI; Webber L, Davies M, Anderson R, et al. ESHRE Guideline: management of women with premature ovarian insufficiency. Hum Reprod. 2016;31(5):926-937.

Nicosia SV. The aging ovary. Med Clin North Am. 1987;71(1):1-9.

te Velde ER, Pearson PL. The variability of female reproductive ageing. Hum Reprod Update. 2002;8(2):141-154.

Bellino FL, Wise PM. Nonhuman primate models of menopause workshop. Biol Reprod. 2003;68(1):10-18.

Durlinger AL, Kramer P, Karels B, et al. Control of primordial follicle recruitment by anti-Müllerian hormone in the mouse ovary. Endocrinology. 1999;140(12):5789-5796.

Stuenkel CA, Gompel A. Primary Ovarian Insufficiency. N Engl J Med. 2023;388(2):154-163.

Vogt EC, Real FG, Husebye ES, et al. Premature menopause and autoimmune primary ovarian insufficiency in two international multi-center cohorts. Endocr Connect. 2022;11(5):e220024.

Aittomäki K, Lucena JL, Pakarinen P, et al. Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell. 1995;82(6):959-968.

Mila M, Alvarez-Mora MI, Madrigal I, Rodriguez-Revenga L. Fragile X syndrome: An overview and update of the FMR1 gene. Clin Genet. 2018;93(2):197-205.

Alvarez-Mora MI, Rodriguez-Revenga L, Madrigal I, et al. Deregulation of key signaling pathways involved in oocyte maturation in FMR1 premutation carriers with Fragile X-associated primary ovarian insufficiency. Gene. 2015;571(1):52-57.

França MM, Mendonca BB. Genetics of ovarian insufficiency and defects of folliculogenesis. Best Pract Res Clin Endocrinol Metab. 2022;36(1):101594.

Podfigurna A, Czyzyk A, Grymowicz M, Smolarczyk R, Blazej Meczekalski B. Primary Ovarian Insufficiency. In Cano A (Eds). Menopause. A comprehensive Approach. Springer, Cham. 2017. pp:23-66.

Hsueh AJ, Kawamura K, Cheng Y, Fauser BC. Intraovarian control of early folliculogenesis. Endocr Rev. 2015;36(1):1-24.

Wang S, Zheng Y, Li J, et al. Single-Cell Transcriptomic Atlas of Primate Ovarian Aging. Cell. 2020;180(3):585-600.e19.

Tarín JJ. Potential effects of age-associated oxidative stress on mammalian oocytes/embryos. Mol Hum Reprod. 1996;2(10):717-724.

Harlow SD, Gass M, Hall JE, et al.; STRAW + 10 Collaborative Group. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Climacteric. 2012;15(2):105-114.

Gold EB, Sternfeld B, Kelsey JL, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol. 2000;152(5):463-473.

Mansfield PK, Carey M, Anderson A, Barsom SH, Koch PB. Staging the menopausal transition: data from the TREMIN Research Program on Women’s Health. Womens Health Issues. 2004;14(6):220-226.

The Melbourne women’s midlife health project [1996-2000]. https://researchdata.edu.au/melbourne-womens-midlife-health-project/97876 (Last access: 9 March 2024.

Woods NF, Mitchell ES. The Seattle Midlife Women’s Health Study: a longitudinal prospective study of women during the menopausal transition and early postmenopause. Womens Midlife Health. 2016;2:6.

Welt CK, McNicholl DJ, Taylor AE, Hall JE. Female reproductive aging is marked by decreased secretion of dimeric inhibin. J Clin Endocrinol Metab. 1999;84(1):105-111.

Shaw ND, Srouji SS, Welt CK, et al. Compensatory Increase in Ovarian Aromatase in Older Regularly Cycling Women. J Clin Endocrinol Metab. 2015;100(9):3539-3547.

Santoro N, Crawford SL, Lasley WL, et al. Factors related to declining luteal function in women during the menopausal transition. J Clin Endocrinol Metab. 2008;93(5):1711-1721.

Santoro N, Crawford SL, El Khoudary SR, et al. Menstrual Cycle Hormone Changes in Women Traversing Menopause: Study of Women’s Health Across the Nation. J Clin Endocrinol Metab. 2017;102(7):2218-2229.

Hawkins SM, Matzuk MM. The menstrual cycle: basic biology. Ann N Y Acad Sci. 2008;1135:10-8.

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2024 Aitana Monllor-Tormos, Rocío Belda-Montesinos, Amparo Carrasco-Catena, Peter Chedraui, Antonio Cano